RSA Viewpoints

What next for EU and UK biotech boards?

In light of the UK’s decision to leave the EU, it’s worth revisiting our recent Talent Equity® report on what makes successful biotech boards. The question...

Future Talent Hard Data and Soft Skills

Imagine 1000 HR professionals in a theatre. Everyone with work and people challenges, mobile phones and email to answer. Cue Martine Wright, a survivor...

Biotech & Money, London, 2016

The meeting focused on harnessing the value of innovation and new models for collaboration. No small task. It had a strong UK focus but...

What Makes Successful Biotech Boards?

This report looks forensically at correlations between company performance and Board composition. From this we draw out lessons that can be learned from the...

Report from JP Morgan 2016

The ‘Salmon Run’ of the Life Sciences is over for another year. Here are some take home messages. Public funding is uncertain but institutional investor coffers are full The withdrawal...